The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma
Cancer Cell International2021Vol. 21(1), pp. 487–487
Citations Over TimeTop 10% of 2021 papers
Yeye Guo, Xu Zhang, Linconghua Wang, Min Li, Minxue Shen, Zhe Zhou, Susi Zhu, Keke Li, Zhiqin Fang, Bei Yan, Shuang Zhao, Juan Su, Xiang Chen, Cong Peng
Abstract
This study indicates that reduced exosomal miR-1180-3p in melanoma patient plasma is a promising diagnostic marker and provides novel insight into melanoma development.
Related Papers
- → Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics(2020)969 cited
- → Unraveling the physiological functions of exosome secretion by tumors(2013)43 cited
- → Exosome subpopulations: The isolation and the functions in diseases(2023)19 cited
- → The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients(2023)13 cited
- → Role of Exosomes in Tuberculosis: Looking towards a Future Road Map(2023)1 cited